An observational study revealed that while leptin and adiponectin were not directly implicated in disease alterations in non-small cell lung carcinoma, resistin, functioning as a pro-inflammatory cytokine, might play a role in the pathogenesis of weight loss in NSCLC patients [36]. Here, ADIPOQ is linked to non-small cell lung carcinoma.